Recent advances and challenges in antibacterial drug development
- PMID: 35350117
- PMCID: PMC8957241
- DOI: 10.5599/admet.1271
Recent advances and challenges in antibacterial drug development
Keywords: Antimicrobial Resistance; Public Health; Research and Development; WHO Pipeline.
Conflict of interest statement
Conflict of interest: No conflict of interest is declared by the authors.
References
-
- Murray C.J., Ikuta K.S., Sharara F., Swetschinski L., Aguilar G.R., Gray A., Han C., Bisignano C., Rao P., Wool E., Johnson S.C.. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 399 (2022) P629-655. https://doi.org/10.1016/S0140-6736(21)02724-0. 10.1016/S0140-6736(21)02724-0 - DOI - PMC - PubMed
-
- Butler M.S., Gigante V., Sati H., Paulin S., Al-Sulaiman L., Rex J.H., Fernandes P., Arias C.A., Paul M., Thwaites G.E., Czaplewski L.. Analysis of the clinical pipeline of treatments for drug resistant bacterial infections: despite progress, more action is needed. Antimicrobial Agents and Chemotherapy (2022) https://doi.org/10.1128/AAC.01991-21. 10.1128/AAC.01991-21 - DOI - PMC - PubMed
-
- Prioritization of pathogens to guide discovery, research, and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis. World Health Organization; 2017. https://apps.who.int/iris/handle/10665/311820.
-
- Antibiotics Currently in Global Clinical Development, Pew’s antibiotic resistance project communication, Updated: March 9, 2021. Available via: Antibiotics Currently in Global Clinical Development | The Pew Charitable Trusts (pewtrusts.org) (Last accessed 01/27/2022).
-
- 2020 Antibacterial agents in clinical and preclinical development: an overview and analysis. Geneva: World Health Organization; 2021. Licence: CC BY-NC-SA 3.0 IGO.
Grants and funding
LinkOut - more resources
Full Text Sources